Does the EU MDR Affect the Insurance Requirements for US Medical Device Companies?

Yes, for any US device company that sells into European markets. The EU Medical Device Regulation created post-market and liability obligations that come with EU-jurisdiction exposure, and most US device insurance programs are written for US exposure. The gap is the space between where the company now sells and where its policy actually responds.

What the EU MDR Adds

The EU MDR imposes its own post-market surveillance and vigilance obligations, with serious-incident and field-safety-corrective-action reporting on tight timelines. A US company placing product into the EU operates under that regime in addition to FDA requirements, which is the same dual-framework reality behind products liability for medical devices. Compliance with the EU MDR satisfies the regulator. It does not, by itself, mean a claim brought in an EU jurisdiction is covered by a US policy, because compliance and coverage are two different questions answered by two different documents.

Where the Coverage Gap Forms

A standard US products liability and general liability program is written with US territory and US jurisdiction in mind. The general territory question that sits underneath EU MDR is covered in whether US medical device insurance reaches international distribution at all. A patient injured in the EU, or a regulator acting there, can produce a claim in a forum the policy was not built to answer. The geographic scope, the jurisdiction clause, and the choice-of-law terms in the policy decide whether the EU claim is defended cleanly or falls outside coverage. Defense cost is its own problem here, because mounting a defense in a foreign forum, in another language and under another legal system, runs well beyond what a US-only program planned for. A company that expanded distribution into Europe without revisiting these terms usually carries a gap it does not know about, the kind that surfaces only when a non-US claim actually arrives. The same coordination question sits behind errors and omissions for a medical device company, where the work product travels with the product into every market it reaches.

EU MDR Compliance Does Not Transfer the Liability Home

A common assumption is that meeting EU MDR requirements, including appointing an EU authorized representative, somehow routes liability back into the familiar US framework. It does not. The authorized representative is a regulatory mechanism, not an insurance one, and EU liability theories and forums apply to the product sold there. The insurance program has to be extended to the EU exposure on purpose, through international coverage terms, rather than assumed to follow along with the compliance work the company already did. There is also a product-liability dimension specific to the EU, where the framework for defective products can reach further up the supply chain than a US company expects, so the manufacturer named on the label carries an exposure that the policy has to be told about in advance.

What to Put in Place

If you sell, or plan to sell, into the EU, confirm your products liability and general liability policies include the geographic and jurisdictional scope to respond to an EU claim, and review the choice-of-law and defense provisions for non-US matters. Multi-country footprints often need a coordinating layer over the local admitted policies, covered in difference in conditions insurance for a life sciences company. Confirm the EU MDR post-market obligations are reflected in how the program treats incident reporting and recall. Then keep the coverage footprint aligned with the distribution footprint as it grows, because the gap forms quietly whenever sales move ahead of the policy. A single distributor agreement or a new country added to the sales map can be enough to put the program out of step, so the review belongs on the same calendar as the expansion.

Before your next renewal, map where your device is actually sold against where your policy actually responds. A specialty review through Tower Street Insurance can confirm a US device company’s program reaches the EU exposure its distribution created.